Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Single Strain Oral Cholera Vaccine Hillchol (BBV131)to the Comparator Vaccine Shanchol Along With Lot-to-lot Consistency of Hillchol (BBV131).

Next Previous
Search
Trial Profile

A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Single Strain Oral Cholera Vaccine Hillchol (BBV131)to the Comparator Vaccine Shanchol Along With Lot-to-lot Consistency of Hillchol (BBV131).

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 30 Aug 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs BBV 131 (Primary) ; Cholera vaccine inactivated (Primary)
  • Indications Cholera
  • Focus Pharmacodynamics; Registrational
  • Sponsors Bharat Biotech

    • Most Recent Events

    • 27 Aug 2024 Status changed to completed, according to Hilleman Laboratories media release
    • 27 Aug 2024 According to Hilleman Laboratories media release, Laboratories has today announced that its partner Bharat Biotech, has successfully launched HILLCHOL, and successful completion of HILLCHOL Phase III clinical trials and approval for licensure by Bharat Biotech in India.
    • 24 Aug 2022 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top